NACC1 and neoplasm: Expression of NACC1 is reported to be associated with poor prognosis of carcinomas in several organs, including the ovaries [4,5], oral cavity [6], colon/rectum [7,8,9], pancreas [10], uterine cervix [11], and prostate [12], as well as hematological [9] and melanocytic [13] neoplasms.